Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q3 FY2019
As of Sep 30, 2019
Q2 FY2019
As of Jun 30, 2019
Q1 FY2019
As of Mar 31, 2019
Q4 FY2018
As of Dec 31, 2018
Q3 FY2018
As of Sep 30, 2018
Q2 FY2018
As of Jun 30, 2018
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Trade accounts receivable—net of allowance for doubtful accounts of $5,560 and $5,803, respectively
Deferred commissions
Prepaid expenses and other current assets
Total current assets before customer fund assets
Funds held from customers
Receivable from customers—net of allowance of $533 and $439, respectively
Total current assets
Noncurrent assets:
Restricted cash
Deferred commissions
Operating lease right-of-use assets—net
Property and equipment—net
Intangible assets—net
Goodwill
Other noncurrent assets
Total assets
Liabilities and shareholders' equity
Current liabilities:
Trade payables
Accrued expenses
Deferred revenue
Accrued purchase price related to acquisitions
Accrued earnout liabilities
Operating lease liabilities
Total current liabilities before customer fund obligations
Customer fund obligations
Total current liabilities
Noncurrent liabilities:
Convertible senior notes—net
Deferred revenue
Accrued purchase price related to acquisitions
Accrued earnout liabilities
Operating lease liabilities
Deferred rent
Deferred tax liability
Other noncurrent liabilities
Total liabilities
Commitments and contingencies
Shareholders' equity:
Preferred stock, $0.0001 par value – no shares issued and outstanding at June 30, 2022, and December 31, 2021, and 20,000 shares authorized as of June 30, 2022, and December 31, 2021
Common stock, $0.0001 par value – 88,123 and 87,087 shares issued and outstanding at June 30, 2022, and December 31, 2021, respectively, and 600,000 shares authorized as of June 30, 2022, and December 31, 2021
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total shareholders’ equity
Total liabilities and shareholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support